RET-Positive Metastatic NSCLC


 

WCLC 2022 on the NADIM II Trial: Pre-Treatment ctDNA Levels Significantly Predict OS & PFS in Locally Advanced & Potentially Resectable NSCLC

84 views
August 18, 2022
0 Comments
Login to view comments. Click here to Login
RET-Positive Metastatic NSCLC